Consensus statements	Level	Grade
•AFP is the only tumor marker that has undergone extensive evaluation.	I
•AFP alone is not recommended either in surveillance or diagnosis of HCC.	II-2	Strong
•High levels of tumor markers are associated with worse prognosis in HCC patients.	I
•AFP may have a role in assessing response to loco-regional therapy and tumor recurrence hence recommended to be done prior to loco-regional therapy.	II-2	Strong
•Molecular classification of HCC is not ready for clinical application.	II-2	Weak